Home / News
-
-
The continuous outbreak of the 2021 epidemic has drawn attention to the issue of upstream raw materials in China's IVD industry.2022-02-14View More
-
-
Bruker on Friday reported that its fourth quarter revenues were up 9 percent year over year, driven by growth across almost all of the firm's business segments.2022-02-14View More
-
-
Along with the development of new therapies, advances in technologies that enable earlier diagnosis of cancer are critical to improve patient outcomes.2022-02-14View More
-
-
On January 30, China Telecom Medical Health Technology Co., Ltd. was established with a registered capital of CNY 200 million.2022-02-11View More
-
-
Illumina reported after the close of the market on Thursday that its fourth quarter 2021 revenues rose 26 percent year over year, narrowly beating its own forecast last month of 25 percent growth.2022-02-11View More
-
-
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced financial results for the fourth quarter and year ended December 31, 2021.2022-02-11View More
-
-
Jiangsu Mole Bioscience obtained the approval of the Helicobacter pylori 23S rRNA gene and gyrA gene mutation test kit (fluorescence PCR method) by NMPA. This kit is the first product in China that can simultaneously detect clarithromycin and levofloxacin resistance genes.2022-02-10View More
-
-
Roche on Thursday reported a 29 percent year-over-year increase in sales in its diagnostics division for full-year 2021, driven by momentum in the base business and continued demand for COVID-19 testing.2022-02-10View More
-
-
Eurofins Scientific said on Wednesday that its subsidiary Eurofins Clinical Testing Lux Sarl has acquired Vietnamese genetic testing firm Genetic Testing Service JSC (Gentis).2022-02-10View More
-
-
On February 7, the U.S. Commerce Department said that it had added 33 Chinese entities to its so-called 'unverified list', which requires U.S. exporters to go through more procedures before shipping goods to the entities.2022-02-09View More
-
-
Qiagen reported after the close of the market on Tuesday that its fourth quarter revenues grew 2 percent year over year, beating previous guidance and analyst estimates on the top and bottom line.2022-02-09View More
-
-
DNA sequencing firm Element Biosciences said on Tuesday that it has acquired Loop Genomics for an undisclosed amount.2022-02-09View More
-
-
On January 29, Shenzhen Tisenc Medical Devices Co., Ltd. underwent an industrial and commercial change. All the original shareholders withdrew, and WONDFO BIOTECH (300482) was newly added, holding 100% of the shares.2022-02-08View More
-
-
Hologic reported after the close of the market on Wednesday that revenues for its first quarter of fiscal year 2022 decreased 9 percent year over year, driven by lower sales of COVID-19 assays.2022-02-08View More
-
-
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its board of directors has approved the planned spinoff of its diabetes care business, which will be known as Embecta Corp.2022-02-08View More
-
-
The ¡°COVID-19 Antigen Rapid Test ¨C Anterior Nasal Swab¡± and the ¡°COVID-19 Antigen Rapid Test (Colloidal Gold) ¨C Saliva¡± developed independently by JOINSTAR Biomedical Technology Co., Ltd obtained the EU CE certification for self-testing on January 20th and February 2nd, issued by the CE 1434.2022-02-07View More
-
-
Becton Dickinson said on Tuesday that it has acquired Cytognos, a privately held developer of flow cytometry-based tests for hematologic cancer and blood diseases, from its parent firm Vitros.2022-02-07View More
-
Medix Biochemica expands its molecular diagnostics business through the acquisition of myPOLS Biotec
-
Medix Biochemica has acquired 100 percent of the shares of myPOLS Biotec GmbH, a German manufacturer of innovative and high-quality raw materials in molecular diagnostics.2022-02-07View More
-
-
Thermo Fisher Scientific on Wednesday morning reported a 1 percent increase in fourth quarter revenues and a 22 percent rise in full-year 2021 revenues. The company also raised its revenue and earnings guidance for 2022.2022-02-07View More
-
-
Two researchers from Skoltech and McGill University have published a review of the promising research field known as structural proteomics in the influential journal Chemical Reviews.2022-01-28View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.